Kirk Mykytyn received his Ph.D. degree in human genetics in 1999 from the University of Utah, Salt Lake City, Utah, USA where he studied cholesterol metabolism in the lab of Dr. James Metherall. He served then as a Postdoctoral Fellow with Dr. Val Sheffield at the University of Iowa, Iowa City, Iowa, where he successfully identified two genes underlying Bardet-Biedl syndrome (BBS) and developed the first mouse model of BBS. Dr. Mykytyn currently works as an Associate Professor in the Department of Pharmacology at the Ohio State University, Ohio, USA. Research in the Mykytyn lab utilizes mouse models to focus on the roles of the BBS proteins in primary cilia function and determine how primary cilia dysfunction leads to disease.
Biography Updated on 5 June 2012